⌘K
Commit Biologics
Healthcare & Life Sciences
Recent Finacing
Seed
Recent Raise
$5.8M
Commit Biologics develops a Bispecific Complement Engaging (BiCE™) platform to target cancer and autoimmune diseases.
Focus Areas
BiCE™ platform
cancer
autoimmune diseases
drug candidate selection
biotechnology.
Investors
